A Study of State-Specific Blood Marker Investigation in Bipolar and Schizoaffective Disorder

Overview

Información sobre este estudio

The purpose of this study is to find out if some patients with mood symptoms have antibodies (part of the immune system) that affect the brain, and could possibly play a role in the development of mood symptoms. We also want to find out if these immune markers change once your mood normalizes.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • Age 18-55, male or female, any race/ethnicity
  • Diagnosis of
    • Bipolar I disorder 
      • Single manic episode
    • Bipolar I disorder 
      • Most recent episode hypomanic, manic, or mixed
    • Bipolar II disorder
      • Most recent episode hypomanic; or schizoaffective disorder, most recent episode hypomanic, manic, or mixed
  • YMRS ≥12

Exclusion Criteria:   

  • Inability to speak English
  • Inability or lack of willingness to provide informed consent, including current involuntary treatment or hospitalization
  • Outpatients with active suicidality as defined by a score of 2 or higher on question # 18 of the Inventory for Depressive Symptoms (IDS)
  • Active psychosis, defined by delusional thought content or hallucinations, as identified by clinical examination or on diagnostic interview.
  • Active or unstable medical condition as evaluated by clinical interviewer
  • Presence of co-morbid Axis I or Axis II disorder that is the primary diagnosis and current focus of treatment

 

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Rochester, Minn.

Investigador principal de Mayo Clinic

Robert Morgan, M.D., Ph.D.

Cerrado para la inscripción

More information

Publicaciones

Publications are currently not available
.
CLS-20310847

Mayo Clinic Footer